Try a new search

Format these results:

Searched for:

Department/Unit:Child and Adolescent Psychiatry

Total Results:

11724


Twelve-Month Cumulative Incidence, Characteristics, and Correlates of Non-adherence in Youths Treated with Second-Generation Antipsychotics for Mental Disorders: Results from a Prospective Cohort Study

Roehrich, Lea A; Solmi, Marco; Cortese, Samuele; Højlund, Mikkel; Salazar-de-Pablo, Gonzalo; Uhlhaas, Peter J; Correll, Christoph U
BACKGROUND:Antipsychotic non-adherence in youths with mental disorders is multifactorial, may remain clinically unnoticed, and has been underresearched. OBJECTIVE:To characterize antipsychotic non-adherence in youths, including its correlates. METHOD/METHODS:Data were collected from the naturalistic Second-Generation Antipsychotic Treatment Indications, Effectiveness and Tolerability in Youth (SATIETY) cohort study, which included youths (ages 4-17 years) who initiated clinician's choice second-generation antipsychotics (SGAs) for psychosis-, mood-, or disruptive behavior-spectrum disorders and had ≥ 1 outpatient day of follow-up. Non-adherence was assessed via interview and antipsychotic plasma levels, and cumulative rates were analyzed via Kaplan-Meyer survival analysis and observed incidences. Characteristics of non-adherence and non-adherent patients were examined. Three multivariable regression models were used to identify predictors of observed cumulative non-adherence over 12 months. RESULTS:= 0.17, p < 0.0001). CONCLUSIONS:One in four youths starting SGAs (increasing in survival analyses accounting for early dropouts to more than one in three youth) discontinued SGAs against medical advice within 12 months, mainly owing to perceived lack of treatment need. As much as 39% of the non-adherence would have remained undetected without SGA plasma level assessments. Interventions should target patient, caregiver, and medication factors to reduce barriers and improve outcomes.
PMID: 42955665
ISSN: 1179-1950
CID: 6074794

A Research-Practice Partnership to Advance Equitable Early Childhood Outcomes Through District-Wide Scaling of a Family-Centered, Evidence-Based Preventive Intervention

Brotman, Laurie M; Kamboukos, Dimitra; Huang, Keng-Yen; Ursache, Alexandra; Barajas-Gonzalez, R Gabriela; Resnick, Jill; Kitrosser, Jeffrey; Delbanco, Yvonne; Kemple, James; Rosenblatt, Katherine; Lashua-Shriftman, Erin; Cheng, Sabrina; Linares Torres, Heliana; Colino, Cirielle; Hamer, Kai-Ama; Dawson-McClure, Spring
Scaling evidence-based interventions (EBIs) in public education systems remains a persistent challenge in prevention science. Although many interventions demonstrate impact in efficacy trials, they are often underused or fail to achieve intended benefits when introduced in routine practice without sufficient implementation support. Research-practice partnerships (RPPs) offer a promising approach for bridging research, policy, and practice; however, few published examples describe how RPPs can support district-wide scale-up and sustainment of EBIs. This article describes an RPP formed to scale ParentCorps-a family-centered EBI developed through community-engaged research-within New York City's universal pre-kindergarten initiative, Pre-K for All. ParentCorps is designed to strengthen family-school partnerships and reduce racial and income disparities in children's educational and mental health outcomes. The partnership brought together the Center for Early Childhood Health and Development (the intervention developer), the NYC Public Schools Division of Early Childhood Education (the implementing system), and the Research Alliance for New York City Schools (a research intermediary). Guided by implementation science frameworks, partners co-designed a series of pragmatic, cluster randomized studies conducted under routine district conditions. We present findings from a pragmatic hybrid type 3 implementation-effectiveness trial that compares two levels of implementation support for ParentCorps. Primary outcomes included pre-K program family engagement practices, assessed using the district's annual system-wide survey; secondary outcomes included parent and child outcomes. We conclude by highlighting the RPP structures, processes, and design choices that enabled rigorous evaluation at scale and discussing implications for how RPPs can build implementation capacity to support district-wide scale-up and sustainment of family-centered EBIs in public education systems.
PMID: 42944833
ISSN: 1573-6695
CID: 6074749

Association of maternal adverse childhood experiences with inflammatory and growth factor pathway activity during pregnancy: a cross-sectional proteomics-based KEGG pathway analysis in the ECHO cohort

Shuffrey, Lauren C; Banker, Sarah M; Shapiro-Thompson, Rosa; Aschner, Judy L; Bennett, Sarah; Bush, Nicole R; Blackwell, Courtney K; Ghassabian, Akhgar; Giamberardino, Stephanie N; Morales, Santiago; Newman, Roger B; Osborne, Lauren M; Sinsel, Sarah E; Sullivan, Alexandra D W; Tung, Irene; Hockett, Christine W; Elliott, Amy J; ,
While maternal histories of adverse childhood experiences (ACEs) have been linked to altered immune signaling during pregnancy, the specific inflammatory pathways underlying these associations remain poorly characterized. We leveraged high-dimensional proteomics to examine associations between maternal ACEs and pregnancy-associated inflammatory signaling pathways defined by the Kyoto Encyclopedia of Genes and Genomes (KEGG) and tested whether these associations were moderated by neighborhood-level social vulnerability during pregnancy. Participants included pregnant individuals enrolled in the Environmental influences on Child Health Outcomes (ECHO) Cohort (N = 770). Circulating inflammatory proteins were assayed from maternal plasma using the Olink Target 96 Inflammation panel. Protein markers were mapped to Human Genome Organisation (HUGO) Gene Nomenclature Committee gene symbols and aggregated into KEGG pathway scores using curated definitions. Linear regression models evaluated associations between continuous maternal ACE scores and each pathway score. Following correction for multiple comparisons, higher maternal ACE exposure was associated with higher activity across 12 KEGG-annotated protein pathways, including AGE-RAGE, non-alcoholic fatty liver disease, chemokine, Th17 differentiation, HIF-1, cellular senescence, Rap1, NOD-like receptor signaling, transcriptional misregulation in cancer, and infection-related pathway signaling. Domain-specific analyses identified the most consistent associations for childhood household dysfunction. Neighborhood-level social vulnerability during pregnancy did not moderate ACE-inflammation associations but was independently associated with higher KSHV infection and NOD-like receptor signaling pathway scores. Together, these findings indicate that maternal ACEs and prenatal social vulnerability are independently associated with small, but directionally consistent, differences in overlapping inflammatory and growth-related protein signals during pregnancy.
PMID: 42957063
ISSN: 1090-2139
CID: 6074799

Guest editorial: Adverse childhood experiences and sleep health, Why context matters! [Editorial]

Chung, Alicia; Huang, Keng-Yen
PMID: 42950617
ISSN: 1532-2955
CID: 6074774

Effects of External Trigeminal Nerve Stimulation on Neurocognitive Functioning in Children and Adolescents With ADHD: A Phase 2b Multicenter Randomized Controlled Trial

Eraydin, Irem Ece; Marhenke, Robert; Stringer, Dominic; Conti, Aldo Alberto; Bozhilova, Natali; Johansson, Lena; Mason, Luke; Bilbow, Andrea; Mehta, Mitul Ashok; Santosh, Paramala; Fiori, Federico; Carter, Ben; Cortese, Samuele; Rubia, Katya
OBJECTIVE/UNASSIGNED:Attention deficit hyperactivity disorder (ADHD) is associated with atypical cognition and related autonomic nervous system regulation. Trigeminal nerve stimulation (TNS) received U.S. Food and Drug Administration clearance as neuromodulation treatment for ADHD based on findings of clinical improvements from a pilot trial that were not confirmed in the authors' larger multicenter UK trial. Effects of TNS on cognition in ADHD, however, are relatively unknown. The authors therefore tested secondary outcomes, that is, short- and longer-term effects of active versus sham TNS in youths with ADHD on a broad neurocognitive task battery, physiological indicators of autonomic nervous system regulation, and head motion. METHODS/UNASSIGNED:In the first confirmatory, multicenter, double-blind, parallel-group, phase 2b randomized sham-controlled trial, 150 youths with ADHD (ages 8-18 years) were assigned to 4 weeks of nightly active (N=75) or sham (N=75) TNS. Cognitive performance was assessed using a comprehensive battery of executive function and attention tasks (inhibition, sustained attention, time estimation, processing speed, and intrasubject response variability) at baseline, posttreatment, and 6-month follow-up. Autonomic nervous system regulation (heart rate, heart rate variability, and electrodermal activity) was measured via a wristband device and head motion with an eye tracker during rest or cognitive testing. RESULTS/UNASSIGNED:Intention-to-treat analysis showed no significant differential treatment effects between active and sham TNS on any cognitive or physiological outcomes after 4 weeks of treatment or on cognitive measures at 6-month follow-up. CONCLUSIONS/UNASSIGNED:TNS does not appear to improve neurocognitive performance, autonomic regulation, or head motion in youths with ADHD, extending negative clinical findings. The findings do not provide evidence to support TNS as a viable treatment to improve cognitive or autonomic nervous system functioning in youths with ADHD.
PMID: 42946688
ISSN: 1535-7228
CID: 6074760

Brain and Cardiometabolic Effects of Major Weight Loss in People With Obesity: Preliminary Cohort Findings

Gaggi, Naomi L; Hurwitz, Brian; Bernal, Jennifer; O'Brien, Courtney; Ren-Fielding, Christine; Lofton, Holly; Chen, Jenny; Saperstein, Aviezer; Lee, Sang Han; Chang, Yun-Juan; Yates, Kathy F; Fieremans, Els; Osorio, Ricardo; Convit, Antonio
OBJECTIVE/UNASSIGNED:Given the overlap between obesity-related metabolic and vascular abnormalities and Alzheimer's disease (AD) risk factors, it is critical to determine whether weight loss improves brain and cardiovascular health. This study examined whether ≥ 40% excess-weight loss is associated with improvements in cardiometabolic risk, brain structure, and cognition. METHODS/UNASSIGNED:The study was a longitudinal study of individuals with obesity undergoing metabolic and bariatric surgery or medical/behavioral weight-loss treatment. Participants were classified at follow-up as weight-loss (WL; ≥ 40% excess-weight loss) or non-weight-loss (nWL; < 40%). All completed medical evaluations, structural MRI, and cognitive testing at baseline and 1 year. RESULTS/UNASSIGNED:At 1 year, the WL group exhibited improvements in BMI, HbA1C, inflammatory, metabolic, and lipid profiles. MRI-based volumetrics revealed increases in subcortical gray-matter volume and preservation of AD-vulnerable regions. Cognitive performance remained unchanged. CONCLUSIONS/UNASSIGNED:Achieving ≥ 40% excess-weight loss was associated with improvements in metabolic health and brain structure, including favorable subcortical volume increases. These findings underscore the potential of sustained weight reduction to mitigate risks linked to metabolic syndromes and neurodegeneration. Longer-term follow-up is warranted to determine whether continued metabolic improvements lead to detectable cognitive gains and additional brain-health benefits beyond 1 year.
PMCID:13720752
PMID: 42964797
ISSN: 2055-2238
CID: 6074823

Optimizing digital wellbeing innovations: A call for personalized, integrated, and contextual approaches

El-Shahawy, Omar; de Maret, Olivier; Dinu, Monica; Johnston, Emily A; Abbasi-Kangevari, Mohsen; Kumar, Manasi; Huang, Keng-Yen; Sherman, Scott E; Beasley, Jeannette M
Rapid proliferation of digital technologies presents a paradox: expanding health access while introducing risks such as digital overload, privacy concerns, and negative mental health impacts. A conceptual and implementation gap remains in defining and optimizing wellbeing in a digital world, particularly because digital wellbeing refers both to interventions intentionally designed to promote health and to everyday digital environments that influence wellbeing indirectly. We convened a multidisciplinary think-tank of 24 scholars in May 2025 at New York University Florence, using a structured, mixed-format process to identify gaps and generate integrative concepts for advancing wellbeing within digital and hybrid care ecosystems. The group found that current digital health tools often fragment wellbeing into siloed biomedical paradigms and may be shaped by commercial incentives that favor engagement over flourishing. Consensus emerged that integrated wellbeing is a multidimensional construct spanning physical, mental, emotional, social, spiritual, and nourishment-related dimensions, supported by technologies only when they augment human relationships, context, and autonomy. Key themes included clearer conceptual boundaries; persistent gaps in design, safety, regulation, and health equity; human-centered frameworks that augment rather than replace human support; bridging digital tools with nourishment and nature-based practices; and personalizing strategies across the lifespan and across low- and high-resource settings.
PMID: 42949861
ISSN: 1744-1706
CID: 6074770

Global Burden of Anorexia Nervosa and Bulimia Nervosa, 1990 to 2023, With Forecasts to 2050: A Global Burden of Disease Study 2023 Analysis

Bai, Ruhai; Dong, Wanyue; Wang, Xu; Zhang, Aihua; Santomauro, Damian F; ,; Aalruz, Hasan; Abiodun, Olumide; Aboagye, Richard Gyan; Aboshanab, Khaled M; Abreu, Lucas Guimarães; Abu Lila, Amr Selim; Abukhadijah, Hana J; Abu-Mahfouz, Mohammad S; Adamu, Nuhu Lawan; Adebiyi, Babatope Oluwadamilare; Adekola, Saheed Ayodeji; Adesina, Miracle Ayomikun; Adewuyi, Habeeb Omoponle; Adhanu, Amaha K; Adonteng-Kissi, Obed; Agordoh, Percival Delali; Agordoh, Salome Wumpini; Agostinis Sobrinho, César; Ahmad, Abdul Momin Rizwan; Ahmad, Khabir; Ahmed, Ali; Ahmed, Md Faisal; Ahmed, Shakeel; Ajele, Kenni Wojujutari; Akeju, Oluwabusayomi O; Akinmade, Oladipo Vincent; Akosile, Wole; Akrami, Ashley E; Al Athamneh, Ahmad; Al Awaidy, Salah; Al Maghaireh, Duaa Fayiz; Al Omari, Omar; Al Zoubi, Mohammad Ahmmad Mahmoud; Alam, Mohammad Khursheed; Alammar, Muath A; Al-Anzi, Shams M F; Albashtawy, Mohammed; Aldhahir, Abdulelah Mastour; Alemayehu, Bezawit Abeje; Alhalabi, Baidaa; Alhalaiqa, Fadwa Naji; Alhawajreh, Mohammad Jamil; Alhumaidi, Ashraf; Ali, Ahmed Naif; Ali, Mohammed Usman; Alinejad Rokny, Hamid; Al-Jabi, Samah W; Alkhatib, Ahmad; Alkubati, Sameer Abdulmalik; Al-Marwani, Sabah; Almazan, Joseph Uy; Al-Raddadi, Rajaa M; Alsaif, Bandar; Alsharari, Abdalkarem Fedgash; Alshawish, Eman; Altaany, Zaid; Altwaijri, Yasmin; Aman Mohammadi, Masoud; Amin, Tarek Tawfik; Amugsi, Dickson A; Anil, Abhishek; Anil Kumar, A H Sruthi; Anjana, Prapti; Anyasodor, Anayochukwu Edward; Arabi, Hossein; Aravkin, Aleksandr Y; Areda, Demelash; Arias de la Torre, Jorge; Armocida, Benedetta; Arnone, Danilo; Arruda, Gustavo Aires; Arystan, Nabiy; Ásgeirsdóttir, Bryndís Björk; Ashraf, Syed Amir; Asiamah-Asare, Bernard Kwadwo Yeboah; Atoyebi, Samuel Babajide; Atra, Yonas Alemu; Ayala, Camila Ospina; Ayuso-Mateos, Jose L; Azzam, Eid M S; B, Sheeba; Bai-Sesay, Alpha Umaru; Balcha, Wondu Feyisa; Balhara, Yatan Pal Singh; Balmori-de-la-Miyar, Jose; Balogun, Olaitan Johnson; Bani Hani, Salam; Bano, Farhat; Barker-Collo, Suzanne Lyn; Barrow, Amadou; Bashir, Muhammad Irfan; Bashir, Shahid; Bashir, Shahid; Bashiri, Azadeh; Bastan, Mohammad-Mahdi; Batra, Kavita; Beeraka, Narasimha M; Belancic, Andrej; Tune, Samiun Nazrin Bente Kamal; Bhadiyadra, Mansi Sanjaykumar; Bhaskar, Sonu; Bhattacharya, Sudip; Bisignano, Catherine; Bizzozero-Peroni, Bruno; Bodur, Mahmut; Botero-Carvajal, Alejandro; Breazu, Andreea; Busari, Akeem Olayinka; C, Senthilkumar; C J, Sanjay; Campos-Nonato, Ismael; Carvalho, Sandra; Castelpietra, Giulio; Cembranel, Francieli; Chadwick, Joshua; Chandika, Rama Mohan; Chandradasa, Miyuru; Chang, Yu; Chen, Hana; Choi, Dong-Woo; Choi, Yun-Jung; Chung, Sunghyun; Cicero, Arrigo Francesco Giuseppe; Cioffi, Iolanda; Clark, Cain C T; Cortese, Samuele; Cosentini, Ilaria; Cosma, Claudia; Cruz-Martins, Natália; Cuenca-Martínez, Ferran; Dadras, Omid; Dagli, Namrata; Dahiya, Neha; Dai, Xiaochen; Dang, Ngoc Bao; Darunde, Rahul Ravindra; Darwesh, Aso Mohammad; de la Torre-Luque, Alejandro; Deekonda, Sindhura; Derseh, Hunegnaw Almaw; Devnath, Nishrita; Din, Sadia; Dönicke, Jasmin; Dumbili, Emeka W; Durmus, Hasan; Eboreime, Ejemai; Ebrahimian Sadabad, Faranak; Eddula, Venkata Ravikanth; Elbarazi, Iffat; Elhoumed, Mohamed; ElNahas, Gihan; Elnour, Asim Ahmed; Elrggal, Mahmoud E; Metwally El-Sayed, Mona; Eltahawy, Abdelgawad Salah; Emesobum, Munachimso Anthony; Esomchi, Collins Nduka; Fagbamigbe, Adeniyi Francis; Fakih, Nour; Faris, MoezAlIslam Ezzat; Faro, Andre; Ashfaq, Fauzia; Fekih-Romdhane, Feten; Filippini, Tommaso; Finnemore, Alexander; Finnemore Capon Diaz, Sofia Catherine; Fischer, Florian; Fogacci, Federica; Forner Álvarez, Carlos; Fusar-Poli, Paolo; Galali, Yaseen; Ganiyu, Khadijat Oladayo; Garlasco, Jacopo; Gebre, Tsion S; Gerami Matin, Ali; Getacher, Lemma; Ghafoury, Roya; Ghamkhar, Arin; Gharaibeh, Lobna; Ghoba, Sama; Gholami, Ehsan; Gholami, Zainab; Gialluisi, Alessandro; Giannouli, Vaitsa; Gilani, Syed Abdullah; Gökulu, Gamze; Golechha, Mahaveer; Golmohammadi, Melika; Gu, Changhao; Gulati, Sheffali; Gutiérrez, Bruno; Habteyesus, Aryamawit; Hallit, Souheil; Hamarasool, Fatimah Othman; Haq, Mohd Anul; Haro, Josep Maria; Has, Eka Mishbahatul Marah; Hasan, Towhid; Haslam, Divna M; Hasnain, Md Saquib; Hay, Simon I; Hendy, Abdelaziz; Hoek, Hans W; Hong, Yu; Hoogar, Praveen; Hossain, Md Sabbir; Hossain, Syed Billal; Hosseinzadeh, Mehdi; Htay, Mila Nu Nu; Husain, Waqar; Ibitoye, Segun Emmanuel; Ibrahim, Fatma Magdi; Ibrahim, Rasha; Abbasi, Aamir Ilyas; Iqbal, Danish; Iqbal, Mujahid; Islam, Md Mojahedul; Islam, Md Saiful; Islam, Md Shahinul; Ispriantari, Aloysia; Iyiola, Oluyinka Ajibola; Jabbarinejad, Roxana; Jacob, Jaison; Jahrami, Haitham; Jaka, Sanobar; Jamal, Arshad; Jayapal, Sathish Kumar; Jayasinghe, Yovanthi Anurangi; Joy, George Vellaramcheril; Jozwiak, Jacek Jerzy; Juweid, Malik E; K, Hema Shree; Kalra, Sanjay; Kang, Kyungmin; Kantipudi, Suvarna Jyothi; Karakasis, Paschalis; Karnam, Reddy Praneeth; Kawafha, Mariam Mofleh; Khacharem, Aïmen; Khader, Yousef Saleh; Khalid, Sidra; Khalifeh, Anas Husam; Khalique, Noman; Khan, Ammar Ahmad; Khan, Iman Waheed; Khan, Mohammad Idreesh; Khan, Ruby; Khan, Zahid; Khasbage, Sameer Uttamaro; Khezeli, Mehdi; Khoshvaght, Parisa; Khotimah, Fireza Husnul; Khubchandani, Jagdish; Kieling, Christian; Kim, Jinho; Kondlahalli, Shivakumar K M; Koomson, Isaac; Kotsis, Konstantinos; Koul, Archana; Kuan, Garry; Kumah, Emmanuel; Kumar, Chandan; Kumar, Manasi; Kumar, Pardeep; Kumar, Rakesh; Kumar, Sumeet; Kurpas, Donata; Kusuma, Dian; Lajunen, Timo; Laksono, Agung Dwi; Lasrado, Savita; Latif, Areeba; Le, Long Khanh-Dao; Lee, Hoi Leong; Lee, Seung Won; Leon-Rojas, Jose E; Li, Mengyi; Li, Zhengrui; Lian, Yanxue; Liaqat, Ambreen; Liu, Yushan; Llanaj, Erand; Lopatkina, Mariia; López-Gil, José Francisco; Luo, Pincheng; Lushchak, Oleh; Lytvyak, Ellina; Ma, Zheng Feei; Mahmood, Nozad Hussein; Mahmoud, Iman Fahmi; Malkamu, Birhanemaskal; Mary, J Jenifer Florence; Mashudi, Sugeng; Mathur, Neeta; Mattiello, Rita; Mattoo, Khurshid A; Mazzola, Giuseppe; Mbachu, Chioma Ngozichukwu Pauline; McGrath, John J; Medina, John Robert Carabeo; Mehboob, Khurram; Mehboob, Riffat; Mehta, Vini; Meto, Tesfahun Mekene; Melariri, Herbert; Memon, Aamir Raoof; Merlino, Giovanni; Mestrovic, Tomislav; Miller, Paul Anthony; Miller, Ted R; Minervini, Giuseppe; Ming, Long Chiau; Mitra, Tridip; Mohamed, Farduus Ibraahim; Mohamed, Fatima Awad Elkarim Elfaki; Mohammed, Mustapha; Mohammed, Zaidan; Moin, Afrasim; Mokdad, Ali H; Molinaro, Sabrina; Monasta, Lorenzo; Morgan, Anthony Kwame; Mosaddeghi-Heris, Reza; Mostafa, Md Shihab; Mughal, Faraz; Murray, Christopher J L; Muthusamy, Sukumar; Myung, Woojae; Nalabothu, Prasad; Naqvi, Rizwan; Nargus, Shumaila; Naureen, Zakira; Nguyen, Cuong Tat; Nguyen, Trang; Nigatu, Yeshambel T; Niranjan, Vikram; Nkemjika, Stanley; Nnyanzi, Lawrence Achilles; Nouri, Mehran; Nzoputam, Chimezie Igwegbe; Nzoputam, Ogochukwu Janet; Okereke, Promise; Olabisi, Oluwaseyi Isaiah; Olagunju, Andrew T; Olorunlana, Adetayo; Ordak, Michal; Ostojic, Sergej M; Otekunrin, Olutosin Ademola; Othman, Mohamed S; Ozsahin, Ilker; Paija, Dimpal Manilal; Palma-Alvarez, Raul Felipe; Paramashanti, Bunga A; Pardhan, Shahina; Parikh, Romil R; Park, Chulwoo; Parmar, Arpit; Patel, Bhargav Umeshchandra; Patel, Mitesh; Patil, Ashlesh; Patil, Shankargouda; Pennisi, Flavia; Pereira, Maria Odete; Perna, Simone; Pham, Hai Quang; Porntavetus, Thantrira; Porru, Fabio; Porwal, Amit; Pourghazi, Farzad; Puvvula, Jagadeesh; Qi, Xiang; Qur'aniati, Nuzul; Radojcic, Maja R; Raggi, Alberto; Raghav, Yashpal Singh; Rahman, Mosiur; Rahmawaty, Setyaningrum; Rajha, Humam; Rajpoot, Pushp Lata; Rakhymbayev, Nurgali Amanbaiuly; Ramadan, Mahmoud Mohammed; Ramadhan, Kadar; Rao, Rajath; Ravi, Dhwani; Rawaf, Salman; Rehman, Ateeq; Rehman, Wajiha; Rizvi, Moattar Raza; Rolfzen, Megan L; Romadlon, Debby Syahru; Ronfani, Luca; Saddik, Basema Ahmad; Sadeghi, Ehsan; Sadek, Bassem; Saeed, Rida Fatima; Sagar, Rajesh; Saghazadeh, Amene; Sagoe, Dominic; Saheb Sharif-Askari, Narjes; Sahin Bodur, Gülsüm; Sahni, Vaibhav; Sahu, Binaya Krushna; Sakshaug, Joseph W; Salaroli, Luciane B; Saleh, Mohamed A; Salum, Giovanni A; Sankararaman, Senthilkumar; Saravanan, Aswini; Saylan, Mete; Sethi, Yashendra; Shaalan, Yara; Shaban-Nejad, Arash; Shaharudin, Shazlin; Shahid, Syed Monowar Alam; Shahini, Endrit; Shahwan, Moyad Jamal; Shaikh, Masood Ali; Shamim, Muhammad Aaqib; Shamsutdinova, Alfiya; Shan, Dan; Sharif, Sumaira; Sharifan, Amin; Sharma, Gaurav; Sharma, Kamlesh; Sharma, Shreya; Sheikh, Nishat Ahmed; Shetty, Premalatha K; Shirali, Priyanka Arun; Shirazi, Shirindokht; Shokouhifar, Mohammad; Shomuyiwa, Deborah Oluwaseun; Siddique, Md Kaoser Bin; Siddiqui, Arif J; Singh, Akanksha; Singh, Harpreet; Singh, Jasvinder A; Singh, Jawahar; Singh, Poornima Suryanath; Singh, Siddharth; Singh, Vanshika; Sridharan, Kannan; Stanculescu, Elena; Stokes, Mark A; Stubbs, Brendon; Sullman, Mark J M; Sultana, Marjia; Tabarés-Seisdedos, Rafael; Tabche, Celine; Taha, Zanan Mohammed-Ameen; Taheri, Niloofar; Tampa, Mircea; Tan, Jianye; Tan, Kit-Aun; Tao, Hongliang; Tayarani-Najaran, Mohammad-Hassan; Tekola, Abainash; Temsah, Reem; Teramoto, Masayuki; Thapar, Rekha; Trabelsi, Khaled; Tran Minh Duc, Nguyen; Trico, Domenico; Tromans, Samuel Joseph; Tsermpini, Evangelia; Tufail, Tabussam; Tuglo, Lawrence Sena; Sambo, Abdulkadir Usman; Vadakkethil Radhakrishnan, Rakesh; Vally, Zahir; Van Der Walt, Giloume; Vanneste, Sven; Verma, Akshaya Kumar; Vigezzi, Giacomo Pietro; Vikram, Vignesh; Almeida von Humboldt, Sofia; Wang, Shu; Wang, Xing; Wang, Yaojie; Wickramasinghe, Nuwan Darshana; Williams, Faustine; Wirtu, Gemechu Kumera; Wonde, Tewodros Eshete; Yamada, Natsuhiko; Yang, Hanwen; Yano, Yuichiro; Yergaliyev, Kuanysh A; Yesodharan, Renjulal; Yismaw, Yazachew Engida; Yon, Dong Keon; Yonemoto, Naohiro; Zafar, Muhammad Sohail; Zamagni, Giulia; Zarea, Kourosh; Zargar, Seema; Zastrozhin, Michael; Zawiah, Mohammed; Zeru, Eyael M; Zhang, Zhichang; Zyoud, Sa'ed H
IMPORTANCE/UNASSIGNED:Eating disorders are a major cause of nonfatal mental health burden, yet global evidence on their long-term trends, geographic distribution, and future trajectories remains limited. OBJECTIVE/UNASSIGNED:To estimate the global, regional, and national prevalence and disability burden of anorexia nervosa and bulimia nervosa-and mortality attributable to anorexia nervosa-from 1990 to 2023, and to forecast prevalence to 2050. DESIGN, SETTING, AND PARTICIPANTS/UNASSIGNED:Using Global Burden of Disease (GBD) 2023 methods, data were synthesized from systematic literature reviews, population surveys, and vital registration systems. Estimates were produced for 204 countries and territories from 1990 to 2023, with forecasts through 2050. These data were analyzed from October 2025 to August 2026. EXPOSURE/UNASSIGNED:Anorexia nervosa or bulimia nervosa diagnosis. MAIN OUTCOMES AND MEASURES/UNASSIGNED:Counts and age-standardized rates with 95% uncertainty intervals (UIs) for anorexia nervosa and bulimia nervosa prevalence, years lived with disability (YLDs), and disability-adjusted life-years (DALYs), and anorexia nervosa mortality, reported by age, sex, and location. RESULTS/UNASSIGNED:In 2023, an estimated 18.1 million people (95% UI, 13.9-24.0) globally were living with anorexia nervosa or bulimia nervosa, of whom 12.6 million (69.4%) were female, 5.5 million were male (30.6%), and 41.2% were aged 10 to 24 years. These cases accounted for 3.83 million DALYs (95% UI, 2.23-5.69). Since 1990, the global number of prevalent cases increased by 71.0%, while age-standardized prevalence and DALY rates rose by about 21%. Females experienced substantially higher prevalence and DALY rates than males. The highest age-standardized prevalence rates were observed in high-income regions, particularly Australasia and Western Europe, whereas the largest relative increases in age-standardized prevalence occurred in East Asia, South Asia, and Southeast Asia. Forecasts indicate continued increases in prevalent cases through 2050. CONCLUSIONS AND RELEVANCE/UNASSIGNED:This GBD 2023 analysis found that anorexia nervosa and bulimia nervosa contribute substantially to global nonfatal health loss. These findings support the integration of eating disorders into mental health surveillance, prevention, and service planning worldwide.
PMCID:13717465
PMID: 42949727
ISSN: 2168-6238
CID: 6074830

Safety and efficacy of psilocybin-assisted therapy for alcohol use disorder: Open-label extension of a phase II randomized controlled trial

Pagni, Broc A; Ross, Stephen; Mennenga, Sarah; Bhatt, Snehal; Zeifman, Richard J; Petridis, Petros D; Carrithers, Brennan M; Worth, Lindsay; Podrebarac, Samantha; Owens, Lindsey T; O'Donnell, Kelley; Roberts, Daniel E; Kim, Yuna; Bogenschutz, Michael P
BACKGROUND:Psilocybin-assisted therapy (PAT) has shown promise for alcohol use disorder (AUD) in randomized controlled trials (RCTs). It remains unknown, however, whether patients derive additional benefit when psilocybin is administered open-label after completion of blinded treatment. Here, we report safety and efficacy outcomes from an open-label extension of a Phase II RCT of PAT for AUD (NCT02061293). METHODS:Fifty-nine adults with AUD received a single open-label administration of psilocybin (25-40mg/70kg) accompanied by four hours of manualized therapy. During the preceding double-blind phase, 29 of these participants had received psilocybin (psilocybin-psilocybin group; PP) and 30 had received the active placebo diphenhydramine (diphenhydramine-psilocybin group; DP). Mixed-effects models for repeated measures evaluated alcohol consumption (percent heavy drinking days [PHDD], drinks per day [DpD], and percent drinking days [PDD]), alcohol craving, abstinence self-efficacy, and treatment readiness across a four-month follow-up. RESULTS:Psilocybin was well tolerated, and no serious adverse events occurred. Among participants with higher drinking intensity at extension entry, decreases in PHDD, DpD, and PDD were observed at Month 1 but returned to entry levels thereafter. Craving, abstinence self-efficacy, and treatment readiness improved in both PP and DP groups one week after administration, with variable trajectories thereafter. DISCUSSION/CONCLUSIONS:After completion of the double-blind trial, a single open-label psilocybin administration was associated with maintained remission among most participants who entered abstinent and with acute but largely transient reductions among those who were still drinking heavily. Whether the limited durability reflects the lower intensity of extension treatment, the relative treatment resistance of residual drinking, differences in motivation, or other design-related factors cannot be determined from these data. CLINICAL TRIAL REGISTRATION/BACKGROUND:NCT02061293, A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence, https://clinicaltrials.gov/study/NCT02061293.
PMID: 42913354
ISSN: 1879-0046
CID: 6074709

Prenatal exposure to SARS-CoV-2, early relational health, and child socio-emotional functioning in the first 6 months

Lavallée, Andréane; Warmingham, Jennifer M; Owen, Jill B; Xu, Ruiyang L; Ahmed, Imaal; Atwood, Ginger D; Kyle, Margaret H; Hussain, Maha; Chaves, Vitoria; Arduin, Elena; Lanoff, Marissa R; Hyman, Sabrina P; Coskun, Lerzan Z; Shearman, Nicole; Russo, Jenna E; Ettinger, Sharon; Greeman, Esther A; Serota, Danielle E; Bence, Mary L; Hott, Violet; Hu, Yunzhe; Kurman, Georgia; Lara, Mayerly; Lopez, Helen Tzul; Mollicone, Isabelle; Ravi, Rupa; Rodriguez, Cynthia; Smotrich, Grace C; Lawless, Aoife; Ontiveros-Ángel, Perla; Curtin, Austen; Austin, Judy; Firestein, Morgan R; Shuffrey, Lauren C; Fernández, Cristina R; Battarbee, Ashley N; Bruno, Ann; Dawood, Fatimah S; Maniatis, Panagiotis; Morrill, Tyler C; Newes-Adeyi, Gabriella; Reichle, Lawrence; Semenova, Vera; Tita, Alan T; Varner, Michael; Wielgosz, Kristina; Marsh, Rachel; Curtin, Paul; Stockwell, Melissa S; Monk, Catherine; Dumitriu, Dani
IMPORTANCE/UNASSIGNED:Parent/caregiver-infant early relational health (ERH) is known to play a critical role in the promotion of socio-emotional functioning and wellbeing across the life course. The negative impact of the COVID-19 pandemic on maternal mental health and secondarily on ERH and child socio-emotional functioning is clear. However, the direct impact of maternal viral exposure during pregnancy on ERH has not been investigated. OBJECTIVE/UNASSIGNED:The goal of this study was to determine the impact of prenatal SARS-CoV-2 exposure on ERH and infant socio-emotional functioning in the first 6 months of life. DESIGN/UNASSIGNED:Mothers with and without SARS-CoV-2 exposure during pregnancy who gave birth from 02/2020 to 09/2021 were enrolled from 05/2020 to 09/2021 in one of two parallel prospective studies (the COVID-19 Mother Baby Outcomes [COMBO] Initiative or the Respiratory Syndrome Coronavirus 2 in Pregnancy and Infancy [ESPI] COMBO sub-study). Mothers reported on their health and the socio-emotional functioning of their infant via online surveys (REDCap) at enrollment, 1, 2, 4, and 6 months. At 4 to 6 months, dyads were invited to participate in a video-based, remote assessment of ERH. PARTICIPANTS/UNASSIGNED:884 mother-infant dyads from three U.S. States (Alabama, New York, and Utah). EXPOSURE/UNASSIGNED:Prenatal SARS-CoV-2. MAIN OUTCOMES AND MEASURES/UNASSIGNED:Edition (ASQ:SE-2). RESULTS/UNASSIGNED:316 (36%) mothers had a positive prenatal SARS-CoV-2 exposure. Prenatal SARS-CoV-2 exposure was associated with an adjusted estimate of ~5% reduction (incidence rate ratio=0.95, 95% confidence interval [0.90, 1.00], p=0.03) in observed maternal caregiving quality, after accounting for postnatal maternal mental health and sociodemographic factors. We found no evidence of effect on other ERH constructs or infant socio-emotional functioning. CONCLUSIONS AND RELEVANCE/UNASSIGNED:In this large prospective cohort study, prenatal SARS-CoV-2 was associated with a small decrement in caregiving quality, but not other ERH constructs or infant socio-emotional functioning. These findings should be interpreted as hypothesis generating and will require replication in independent studies.
PMCID:13015689
PMID: 41891001
CID: 6074493